These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29094298)

  • 1. Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations.
    Deerochanawong C; Bajpai S; Dwipayana IMP; Hussein Z; Mabunay MA; Rosales R; Tsai ST; Tsang MW
    Diabetes Ther; 2017 Dec; 8(6):1197-1214. PubMed ID: 29094298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus.
    Chan SP; Aamir AH; Bee YM; Deerochanawong C; Paz-Pacheco E; Tiu F; Foo SH; Tan KEK; Le TQ; Saraswati MR; Bunnag P; Panusunan Sibarani R; Raza SA; Tran NQ
    Diabetes Ther; 2022 Aug; 13(8):1511-1529. PubMed ID: 35767186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response.
    Gu T; Hong T; Zhang P; Tang S; Bi Y; Lu H; Men L; Ma D; Zhu D
    Diabetes Ther; 2018 Apr; 9(2):771-787. PubMed ID: 29524190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal Insulin Titration: Moving Towards a More Patient-Centric Approach with Gla-100 in India.
    Madhu SV; Neelaveni K; Pitale S; Somani S; Pandey AK; Kalra P; Ceaser R; Mohanasundaram S; Mohan V
    J Assoc Physicians India; 2020 Dec; 68(12[Special]):38-42. PubMed ID: 33247662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method.
    Jain SM; Seshadri K; Unnikrishnan AG; Chawla M; Kalra P; Vipin VP; Ravishankar E; Chordia J; Das S; Wasir J; Bandookwala SM; Deka N; Agarwal G; Vijaykumar G; Erande S
    Diabetes Ther; 2020 Mar; 11(3):621-632. PubMed ID: 32009224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.
    Hong EG; Min KW; Lim JS; Ahn KJ; Ahn CW; Yu JM; Kim HS; Kim HJ; Kim W; Kim DH; Jang HC
    Adv Ther; 2024 May; 41(5):1967-1982. PubMed ID: 38512540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
    Bonadonna RC; Giaccari A; Buzzetti R; Perseghin G; Cucinotta D; Avogaro A; Aimaretti G; Larosa M; Fanelli CG; Bolli GB
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3304. PubMed ID: 32118347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS).
    ATLAS Study Group
    Diabetes Technol Ther; 2011 Jan; 13(1):67-72. PubMed ID: 21175274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS).
    Misra A; Patel M; Agarwal P; Lodha S; Tandon N; Magdum M; Yajnik C; Ghosh R; Walekar A
    Diabetes Technol Ther; 2019 Nov; 21(11):656-664. PubMed ID: 31335198
    [No Abstract]   [Full Text] [Related]  

  • 11. Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs.
    Seufert J; Fritsche A; Pscherer S; Anderten H; Borck A; Pegelow K; Bramlage P; Pfohl M
    Diabetes Obes Metab; 2019 Feb; 21(2):439-443. PubMed ID: 30226296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.
    Freemantle N; Mauricio D; Giaccari A; Bailey T; Roussel R; Franco D; Berthou B; Pilorget V; Westerbacka J; Bosnyak Z; Bonnemaire M; Cali AMG; Nguyên-Pascal ML; Penfornis A; Perez-Maraver M; Seufert J; Sullivan SD; Wilding J; Wysham C; Davies M
    Curr Med Res Opin; 2020 Apr; 36(4):571-581. PubMed ID: 31865758
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study.
    Sethi B; Al-Rubeaan K; Unubol M; Mabunay MA; Berthou B; Pilorget V; Vethakkan SR; Frechtel G
    Diabetes Ther; 2022 Jul; 13(7):1395-1408. PubMed ID: 35713873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment.
    Tien KJ; Hung YJ; Chen JF; Chen CC; Wang CY; Hwu CM; Huang YY; Hsiao PJ; Tu ST; Wang CH; Sheu WH
    J Diabetes Investig; 2019 May; 10(3):560-570. PubMed ID: 30520564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Examination of Initiation of Long-Acting Insulin Analogs Toujeo Compared to Lantus Under 3 Dosing Titration Rules in Virtual Type 2 Diabetes Subjects.
    Sieber J; Weinheimer M; Kongable G; Riddle S; Chang YY; Flacke F
    J Diabetes Sci Technol; 2020 Sep; 14(5):898-907. PubMed ID: 31288531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.
    Bonadonna RC; Giaccari A; Buzzetti R; Aimaretti G; Cucinotta D; Avogaro A; Perseghin G; Larosa M; Bolli GB; Fanelli CG
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):496-503. PubMed ID: 30952575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.
    Chan WB; Chen JF; Goh SY; Vu TTH; Isip-Tan IT; Mudjanarko SW; Bajpai S; Mabunay MA; Bunnag P
    Diabetes Metab Syndr Obes; 2017; 10():521-532. PubMed ID: 29276400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study.
    Velojic-Golubovic M; Ciric V; Dimitrijevic M; Kovic T; Mitic M; Olujic B; Pevac N; Radenkovic S; Radojkovic D; Vukadinovic S; Popovic DS
    Diabetes Ther; 2021 Jul; 12(7):2049-2058. PubMed ID: 34160790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel.
    Chawla M; Jain SM; Kesavadev J; Makkar BM; Viswanathan V; Tiwaskar M; Sosale AR; Negalur V; Modi KD; Gupta M; Kumar S; Ramakrishnan S; Deka N; Roy N
    Diabetes Ther; 2021 Jan; 12(1):133-142. PubMed ID: 33314000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.